Fong KM - Search Results

1

Gene expression signature predicts recurrence in lung adenocarcinoma.

Larsen JE, Pavey SJ, Passmore LH, Bowman RV, Hayward NK, Fong KM. Larsen JE, et al. Among authors: fong km. Clin Cancer Res. 2007 May 15;13(10):2946-54. doi: 10.1158/1078-0432.CCR-06-2525. Clin Cancer Res. 2007. PMID: 17504995

2

KRAS codon 12 mutations in Australian non-small cell lung cancer.

Fong KM, Zimmerman PV, Smith PJ. Fong KM, et al. Aust N Z J Med. 1998 Apr;28(2):184-9. doi: 10.1111/j.1445-5994.1998.tb02967.x. Aust N Z J Med. 1998. PMID: 9612526

3

TIMP1 and adverse prognosis in non-small cell lung cancer.

Fong KM, Kida Y, Zimmerman PV, Smith PJ. Fong KM, et al. Clin Cancer Res. 1996 Aug;2(8):1369-72. Clin Cancer Res. 1996. PMID: 9816309

4

Molecular biology of lung cancer: clinical implications.

Fong KM, Minna JD. Fong KM, et al. Clin Chest Med. 2002 Mar;23(1):83-101. doi: 10.1016/s0272-5231(03)00062-5. Clin Chest Med. 2002. PMID: 11901922 Review.

5

Re: Effects of N-(4-hydroxy-phenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.

Bowman R, Clarke B, Duhig E, Larsen J, Fong K. Bowman R, et al. J Natl Cancer Inst. 2002 Jun 19;94(12):949-50; author reply 950-1. doi: 10.1093/jnci/94.12.949-a. J Natl Cancer Inst. 2002. PMID: 12072549 No abstract available.

6

A molecular chink in the lung cancer armour.

Fong KM, Bowman R. Fong KM, et al. Respirology. 2004 Nov;9(4):426-7. doi: 10.1111/j.1440-1843.2004.00672c.x. Respirology. 2004. PMID: 15612952 Review. No abstract available.

7

Cochrane systematic reviews of treatments for lung cancer.

Fong KM, Yang IA, Zimmerman PV, Bowman RV. Fong KM, et al. Respir Med. 2005 Sep;99(9):1071-8. doi: 10.1016/j.rmed.2005.05.002. Respir Med. 2005. PMID: 15955688 Free article. Review.

8

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.

Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Larsen JE, et al. Among authors: fong km. Cancer Causes Control. 2005 Jun;16(5):579-85. doi: 10.1007/s10552-004-7842-3. Cancer Causes Control. 2005. PMID: 15986113

9

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.

Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Larsen JE, et al. Among authors: fong km. Carcinogenesis. 2006 Mar;27(3):525-32. doi: 10.1093/carcin/bgi227. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195240

10

Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in Queensland.

Coory M, Fong K, Bowman R, Hall L. Coory M, et al. Intern Med J. 2006 Jun;36(6):389-92. doi: 10.1111/j.1445-5994.2006.01074.x. Intern Med J. 2006. PMID: 16732867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters